Overview

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Amlodipine in patients with early endometrial carcinoma (EEC) for conservative treatment.
Phase:
PHASE2
Details
Lead Sponsor:
Peking University People's Hospital
Treatments:
Amlodipine